nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Coordination abnormal—Varenicline—nicotine dependence	0.0191	0.0284	CcSEcCtD
Terazosin—Musculoskeletal pain—Varenicline—nicotine dependence	0.019	0.0282	CcSEcCtD
Terazosin—Abnormal dreams—Varenicline—nicotine dependence	0.0186	0.0276	CcSEcCtD
Terazosin—Libido decreased—Varenicline—nicotine dependence	0.0147	0.0218	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNB3—nicotine dependence	0.0145	0.0461	CbGpPWpGaD
Terazosin—Atrial fibrillation—Varenicline—nicotine dependence	0.0144	0.0214	CcSEcCtD
Terazosin—Arthritis—Varenicline—nicotine dependence	0.014	0.0208	CcSEcCtD
Terazosin—Cerebrovascular accident—Varenicline—nicotine dependence	0.0139	0.0207	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNA6—nicotine dependence	0.0138	0.0437	CbGpPWpGaD
Terazosin—Osteoarthritis—Varenicline—nicotine dependence	0.0136	0.0202	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0135	0.0201	CcSEcCtD
Terazosin—Migraine—Varenicline—nicotine dependence	0.0134	0.0199	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNB3—nicotine dependence	0.013	0.0411	CbGpPWpGaD
Terazosin—Hypokalaemia—Varenicline—nicotine dependence	0.0124	0.0184	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNA6—nicotine dependence	0.0123	0.039	CbGpPWpGaD
Terazosin—Nasopharyngitis—Varenicline—nicotine dependence	0.0122	0.0181	CcSEcCtD
Terazosin—Gastritis—Varenicline—nicotine dependence	0.0121	0.0179	CcSEcCtD
Terazosin—Asthma—Varenicline—nicotine dependence	0.0118	0.0175	CcSEcCtD
Terazosin—Angina pectoris—Varenicline—nicotine dependence	0.0115	0.017	CcSEcCtD
Terazosin—Bronchitis—Varenicline—nicotine dependence	0.0113	0.0168	CcSEcCtD
Terazosin—Pollakiuria—Varenicline—nicotine dependence	0.0109	0.0162	CcSEcCtD
Terazosin—Erectile dysfunction—Varenicline—nicotine dependence	0.0109	0.0161	CcSEcCtD
Terazosin—Photosensitivity reaction—Varenicline—nicotine dependence	0.0108	0.016	CcSEcCtD
Terazosin—Weight increased—Varenicline—nicotine dependence	0.0107	0.0159	CcSEcCtD
Terazosin—Depression—Varenicline—nicotine dependence	0.0105	0.0156	CcSEcCtD
Terazosin—Conjunctivitis—Varenicline—nicotine dependence	0.0102	0.0152	CcSEcCtD
Terazosin—KCNH6—Neuronal System—GABRA4—nicotine dependence	0.00997	0.0316	CbGpPWpGaD
Terazosin—Epistaxis—Varenicline—nicotine dependence	0.00991	0.0147	CcSEcCtD
Terazosin—Sinusitis—Varenicline—nicotine dependence	0.00986	0.0146	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNB4—nicotine dependence	0.00956	0.0303	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00944	0.0299	CbGpPWpGaD
Terazosin—Oedema peripheral—Varenicline—nicotine dependence	0.00929	0.0138	CcSEcCtD
Terazosin—Visual impairment—Varenicline—nicotine dependence	0.00909	0.0135	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNA5—nicotine dependence	0.00889	0.0282	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—GABRA4—nicotine dependence	0.00889	0.0282	CbGpPWpGaD
Terazosin—Eye disorder—Varenicline—nicotine dependence	0.00881	0.0131	CcSEcCtD
Terazosin—Tinnitus—Varenicline—nicotine dependence	0.00879	0.0131	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNB4—nicotine dependence	0.00852	0.027	CbGpPWpGaD
Terazosin—Arrhythmia—Varenicline—nicotine dependence	0.00842	0.0125	CcSEcCtD
Terazosin—Malnutrition—Varenicline—nicotine dependence	0.00821	0.0122	CcSEcCtD
Terazosin—Flatulence—Varenicline—nicotine dependence	0.00809	0.012	CcSEcCtD
Terazosin—Dysgeusia—Varenicline—nicotine dependence	0.00804	0.0119	CcSEcCtD
Terazosin—Back pain—Varenicline—nicotine dependence	0.00794	0.0118	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNA5—nicotine dependence	0.00792	0.0251	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00783	0.0248	CbGpPWpGaD
Terazosin—Vision blurred—Varenicline—nicotine dependence	0.00774	0.0115	CcSEcCtD
Terazosin—Tremor—Varenicline—nicotine dependence	0.00769	0.0114	CcSEcCtD
Terazosin—Ill-defined disorder—Varenicline—nicotine dependence	0.00762	0.0113	CcSEcCtD
Terazosin—Angioedema—Varenicline—nicotine dependence	0.0075	0.0111	CcSEcCtD
Terazosin—Malaise—Varenicline—nicotine dependence	0.0074	0.011	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00739	0.0234	CbGpPWpGaD
Terazosin—Vertigo—Varenicline—nicotine dependence	0.00738	0.0109	CcSEcCtD
Terazosin—Syncope—Varenicline—nicotine dependence	0.00736	0.0109	CcSEcCtD
Terazosin—Palpitations—Varenicline—nicotine dependence	0.00725	0.0108	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNA3—nicotine dependence	0.00725	0.023	CbGpPWpGaD
Terazosin—Loss of consciousness—Varenicline—nicotine dependence	0.00722	0.0107	CcSEcCtD
Terazosin—Cough—Varenicline—nicotine dependence	0.00716	0.0106	CcSEcCtD
Terazosin—Convulsion—Varenicline—nicotine dependence	0.00711	0.0106	CcSEcCtD
Terazosin—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00707	0.0224	CbGpPWpGaD
Terazosin—Myalgia—Varenicline—nicotine dependence	0.00699	0.0104	CcSEcCtD
Terazosin—Chest pain—Varenicline—nicotine dependence	0.00699	0.0104	CcSEcCtD
Terazosin—Arthralgia—Varenicline—nicotine dependence	0.00699	0.0104	CcSEcCtD
Terazosin—Anxiety—Varenicline—nicotine dependence	0.00696	0.0103	CcSEcCtD
Terazosin—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00696	0.022	CbGpPWpGaD
Terazosin—Discomfort—Varenicline—nicotine dependence	0.00691	0.0103	CcSEcCtD
Terazosin—Dry mouth—Varenicline—nicotine dependence	0.00684	0.0101	CcSEcCtD
Terazosin—Oedema—Varenicline—nicotine dependence	0.0067	0.00995	CcSEcCtD
Terazosin—Shock—Varenicline—nicotine dependence	0.00659	0.00979	CcSEcCtD
Terazosin—Thrombocytopenia—Varenicline—nicotine dependence	0.00656	0.00974	CcSEcCtD
Terazosin—Tachycardia—Varenicline—nicotine dependence	0.00654	0.00971	CcSEcCtD
Terazosin—Hyperhidrosis—Varenicline—nicotine dependence	0.00648	0.00962	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNA3—nicotine dependence	0.00646	0.0205	CbGpPWpGaD
Terazosin—Anorexia—Varenicline—nicotine dependence	0.00639	0.00948	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNB2—nicotine dependence	0.00638	0.0202	CbGpPWpGaD
Terazosin—Hypotension—Varenicline—nicotine dependence	0.00626	0.00929	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0061	0.00906	CcSEcCtD
Terazosin—Insomnia—Varenicline—nicotine dependence	0.00606	0.009	CcSEcCtD
Terazosin—Dyspnoea—Varenicline—nicotine dependence	0.00597	0.00887	CcSEcCtD
Terazosin—Somnolence—Varenicline—nicotine dependence	0.00596	0.00884	CcSEcCtD
Terazosin—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00594	0.0188	CbGpPWpGaD
Terazosin—Dyspepsia—Varenicline—nicotine dependence	0.0059	0.00876	CcSEcCtD
Terazosin—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00587	0.0186	CbGpPWpGaD
Terazosin—Decreased appetite—Varenicline—nicotine dependence	0.00582	0.00865	CcSEcCtD
Terazosin—KCNH6—Neuronal System—CHRNA4—nicotine dependence	0.00579	0.0184	CbGpPWpGaD
Terazosin—Fatigue—Varenicline—nicotine dependence	0.00578	0.00858	CcSEcCtD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00574	0.0182	CbGpPWpGaD
Terazosin—Constipation—Varenicline—nicotine dependence	0.00573	0.00851	CcSEcCtD
Terazosin—Pain—Varenicline—nicotine dependence	0.00573	0.00851	CcSEcCtD
Terazosin—KCNH7—Neuronal System—CHRNB2—nicotine dependence	0.00569	0.018	CbGpPWpGaD
Terazosin—Feeling abnormal—Varenicline—nicotine dependence	0.00552	0.0082	CcSEcCtD
Terazosin—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00549	0.0174	CbGpPWpGaD
Terazosin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00548	0.00813	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—DRD2—nicotine dependence	0.00546	0.0173	CbGpPWpGaD
Terazosin—Body temperature increased—Varenicline—nicotine dependence	0.0053	0.00786	CcSEcCtD
Terazosin—Abdominal pain—Varenicline—nicotine dependence	0.0053	0.00786	CcSEcCtD
Terazosin—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00521	0.0165	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00521	0.0165	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—CHRNA4—nicotine dependence	0.00516	0.0164	CbGpPWpGaD
Terazosin—Hypersensitivity—Varenicline—nicotine dependence	0.00494	0.00733	CcSEcCtD
Terazosin—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00493	0.0156	CbGpPWpGaD
Terazosin—Asthenia—Varenicline—nicotine dependence	0.00481	0.00714	CcSEcCtD
Terazosin—Pruritus—Varenicline—nicotine dependence	0.00474	0.00704	CcSEcCtD
Terazosin—Diarrhoea—Varenicline—nicotine dependence	0.00458	0.00681	CcSEcCtD
Terazosin—Dizziness—Varenicline—nicotine dependence	0.00443	0.00658	CcSEcCtD
Terazosin—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00438	0.0139	CbGpPWpGaD
Terazosin—Vomiting—Varenicline—nicotine dependence	0.00426	0.00632	CcSEcCtD
Terazosin—Rash—Varenicline—nicotine dependence	0.00422	0.00627	CcSEcCtD
Terazosin—Dermatitis—Varenicline—nicotine dependence	0.00422	0.00627	CcSEcCtD
Terazosin—Headache—Varenicline—nicotine dependence	0.0042	0.00623	CcSEcCtD
Terazosin—Nausea—Varenicline—nicotine dependence	0.00398	0.00591	CcSEcCtD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00383	0.0121	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00376	0.0119	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00361	0.0114	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00348	0.011	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00335	0.0106	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00292	0.00925	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00273	0.00866	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00242	0.00768	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00241	0.00763	CbGpPWpGaD
Terazosin—KCNH7—brain—nicotine dependence	0.00233	0.215	CbGeAlD
Terazosin—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.00219	0.00693	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00215	0.00682	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00189	0.00598	CbGpPWpGaD
Terazosin—KCNH6—brain—nicotine dependence	0.00166	0.153	CbGeAlD
Terazosin—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00165	0.00523	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00162	0.00512	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00157	0.00496	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.0015	0.00475	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00139	0.00441	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00137	0.00434	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00136	0.00432	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00134	0.00425	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00129	0.0041	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00124	0.00394	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00123	0.0039	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00122	0.00385	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00119	0.00378	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00118	0.00373	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00117	0.0037	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00113	0.00359	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.0011	0.0035	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00107	0.00341	CbGpPWpGaD
Terazosin—ADRA1A—cardiovascular system—nicotine dependence	0.00107	0.0992	CbGeAlD
Terazosin—KCNH2—cardiovascular system—nicotine dependence	0.00104	0.0958	CbGeAlD
Terazosin—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00102	0.00324	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00101	0.00319	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000976	0.00309	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00097	0.00307	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000955	0.00302	CbGpPWpGaD
Terazosin—ADRA1B—brain—nicotine dependence	0.000938	0.0867	CbGeAlD
Terazosin—ADRA1D—brain—nicotine dependence	0.000918	0.0848	CbGeAlD
Terazosin—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000907	0.00288	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.00089	0.00282	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000885	0.0028	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000867	0.00275	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000862	0.00273	CbGpPWpGaD
Terazosin—KCNH2—midbrain—nicotine dependence	0.00081	0.0748	CbGeAlD
Terazosin—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000739	0.00234	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000735	0.00233	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000696	0.0022	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000695	0.0022	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00069	0.00219	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000656	0.00208	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000653	0.00207	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000632	0.002	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000614	0.00194	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000577	0.00183	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000576	0.00183	CbGpPWpGaD
Terazosin—ADRA1A—brain—nicotine dependence	0.000527	0.0487	CbGeAlD
Terazosin—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000524	0.00166	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000513	0.00162	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000512	0.00162	CbGpPWpGaD
Terazosin—KCNH2—brain—nicotine dependence	0.000509	0.047	CbGeAlD
Terazosin—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000509	0.00161	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000503	0.00159	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000466	0.00148	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000457	0.00145	CbGpPWpGaD
Terazosin—ABCB1—cardiovascular system—nicotine dependence	0.000455	0.042	CbGeAlD
Terazosin—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000452	0.00143	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000432	0.00137	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000417	0.00132	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000414	0.00131	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000379	0.0012	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000373	0.00118	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000371	0.00117	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000359	0.00114	CbGpPWpGaD
Terazosin—ABCB1—midbrain—nicotine dependence	0.000356	0.0328	CbGeAlD
Terazosin—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000344	0.00109	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000337	0.00107	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000323	0.00102	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000319	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.00031	0.000981	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000306	0.000968	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000275	0.000872	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.00027	0.000855	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000224	0.00071	CbGpPWpGaD
Terazosin—ABCB1—brain—nicotine dependence	0.000223	0.0206	CbGeAlD
Terazosin—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000199	0.00063	CbGpPWpGaD
